WASHINGTON – As families face inflation
and other barriers in affording their medications, Sens. Chuck Grassley
(R-Iowa) and Joni Ernst (R-Iowa) want to make sure Iowans have easy access to
the numerous programs and resources available right now to assist with the
costs for insulin and other drugs.
Their new measure — called the Insulin For Our Reoccurring Medical Needs
Act, or INFORM Act — puts all of
the information about these programs online and in one place, making it easier
for families to receive the help they need. It also distributes physical,
printed information about these resources to prescribing locations, like
community health centers, hospitals and pharmacies so that families have all
available information when they pick up their prescription.
“While we continue working on efforts to
lower prescription drug costs, including the cost of insulin, there are steps
we can take to make insulin resources easily accessible. The INFORM Act will provide Iowans with a
one-stop-shop to help individuals in need of insulin save time and money,” Grassley said.
“I’ve long pushed for ways to bring drug
costs down, and I will continue to work across the aisle on bipartisan
solutions to do that, but with resources and assistance programs available
right now to help folks in need, there’s no reason our families and individuals
shouldn’t have every opportunity to save on drug costs,” Ernst said. “This effort will put all of these resources in one,
easily accessible place online as well as in physical locations where patients
go regularly to pick up prescriptions, like pharmacies, hospitals, and
community health centers.”
The INFORM
Act would direct the Department of Health and Human Services (HHS) to
compile information on assistance programs for insulin and other
pharmaceuticals, which are administered by drug manufacturers and nonprofits,
and to display the information clearly on their website. It would also direct
HHS to distribute print materials to health facilities including prescribing
locations.
Grassley is a longtime advocate and
fighter for lowering prescription drug costs, including through his
Prescription Drug Pricing Reduction Act
(PDPRA), which passed the Finance Committee under his leadership, and through
the
Pharmacy
Benefit Manager Transparency Act, which passed the Commerce Committee yesterday.
-30-